Literature DB >> 26201627

Analysis of discordance between transient elastography and liver biopsy for assessing liver fibrosis in chronic hepatitis B virus infection.

Manoj Kumar1, Archana Rastogi2, Tarandeep Singh3, Chhagan Bihari2, Ekta Gupta4, Praveen Sharma3, Hitendra Garg3, Ramesh Kumar3, Vikram Bhatia3, Pankaj Tyagi3, Shiv K Sarin5.   

Abstract

BACKGROUND: Transient elastography (TE) is used to assess liver fibrosis in chronic hepatitis B virus (CHBV) infection. However, factors affecting liver stiffness (LS) values and discordance between TE and liver biopsy in CHBV infection remain to be evaluated. AIM: The aim is to define the optimal cutoff values of LS for significant fibrosis (≥F2) and cirrhosis (F4) and to study the clinical and histological variables associated with LS values and discordance between TE and liver biopsy in assessing liver fibrosis in CHBV-infected subjects.
METHODS: Patients with CHBV infection (n = 200; 159 male; age 37.6 ± 3.7 years) underwent liver biopsy concomitantly with TE. Liver biopsy was scored for activity (Ishak score), fibrosis (METAVIR score), steatosis, cholestasis, and congestion. Hepatic fibrosis percentage was estimated by morphometry.
RESULTS: Liver stiffness values were significantly correlated with histological activity index (HAI) score, F score, and fibrosis percentage. Optimal cutoff values for prediction of significant fibrosis and cirrhosis were 7.05 kPa [sensitivity 81.2 %; specificity 74 %; area under the receiver operating characteristic curve (AUROC) 0.850] and 10.85 kPa (sensitivity 87 %; specificity 85.3 %; AUROC 0.907), respectively. A total of 47 (23.5 %) [overestimation of actual fibrosis by TE, 34 (17 %); underestimation, 13 (6.5 %)] and 28 (14 %) [overestimation, 25 (12.5 %); underestimation, 3 (1.5 %)] patients showed discrepant results for diagnosis of significant fibrosis and cirrhosis, respectively. HAI and interquartile range (IQR) were the factors predictive of overestimation in cirrhosis.
CONCLUSIONS: Fibrosis and necroinflammatory activity are the main determinants of TE in CHBV infection. Overestimation of actual fibrosis stage by TE is common and is influenced by necroinflammatory activity and IQR for estimation of cirrhosis.

Entities:  

Keywords:  Chronic hepatitis B; Fibrosis; Liver stiffness; Non-invasive markers

Year:  2012        PMID: 26201627     DOI: 10.1007/s12072-012-9380-5

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  25 in total

1.  Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages.

Authors:  Thierry Poynard; Philippe Halfon; Laurent Castera; Mona Munteanu; Françoise Imbert-Bismut; Vlad Ratziu; Yves Benhamou; Marc Bourlière; Victor de Ledinghen
Journal:  Clin Chem       Date:  2007-07-18       Impact factor: 8.327

2.  Liver biopsy: the best, not the gold standard.

Authors:  Pierre Bedossa; Fabrice Carrat
Journal:  J Hepatol       Date:  2008-11-06       Impact factor: 25.083

Review 3.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

4.  Liver stiffness is directly influenced by central venous pressure.

Authors:  Gunda Millonig; Stefanie Friedrich; Stefanie Adolf; Hamidreza Fonouni; Mohammad Golriz; Arianeb Mehrabi; Peter Stiefel; Gudrun Pöschl; Markus W Büchler; Helmut Karl Seitz; Sebastian Mueller
Journal:  J Hepatol       Date:  2009-12-04       Impact factor: 25.083

5.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

6.  Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.

Authors:  J Foucher; E Chanteloup; J Vergniol; L Castéra; B Le Bail; X Adhoute; J Bertet; P Couzigou; V de Lédinghen
Journal:  Gut       Date:  2005-07-14       Impact factor: 23.059

7.  Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C.

Authors:  Damien Lucidarme; Juliette Foucher; Brigitte Le Bail; Julien Vergniol; Laurent Castera; Clotilde Duburque; Gérard Forzy; Bernard Filoche; Patrice Couzigou; Victor de Lédinghen
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

8.  Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.

Authors:  H L-Y Chan; G L-H Wong; P C-L Choi; A W-H Chan; A M-L Chim; K K-L Yiu; F K-L Chan; J J-Y Sung; V W-S Wong
Journal:  J Viral Hepat       Date:  2008-07-28       Impact factor: 3.728

9.  Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis.

Authors:  Zachary D Goodman; Robert L Becker; Paul J Pockros; Nezam H Afdhal
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

10.  Exceeding the limits of liver histology markers.

Authors:  Shruti H Mehta; Bryan Lau; Nezam H Afdhal; David L Thomas
Journal:  J Hepatol       Date:  2008-10-18       Impact factor: 25.083

View more
  5 in total

1.  Performance of shear wave elastography: A single centre pilot study of mixed etiology liver disease patients with normal BMI.

Authors:  Shalini Thapar Laroia; Shyam Vellore Srinivasan; Komal Yadav; Archana Rastogi; Senthil Kumar; Guresh Kumar; Manoj Kumar
Journal:  Australas J Ultrasound Med       Date:  2021-05-09

2.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

3.  Pre-therapy liver transcriptome landscape in Indian and French patients with severe alcoholic hepatitis and steroid responsiveness.

Authors:  Shvetank Sharma; Jaswinder S Maras; Sukanta Das; Shabir Hussain; Ashwani K Mishra; Saggere M Shasthry; Chhagan B Sharma; Emmanuel Weiss; Laure Elkrief; Pierre-Emmanuel Rautou; Hélène Gilgenkrantz; Sophie Lotersztajn; Valérie Paradis; Pierre de la Grange; Christophe Junot; Richard Moreau; Shiv K Sarin
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

4.  Performance of common imaging techniques vs serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis.

Authors:  Xue-Ying Xu; Wu-Sheng Wang; Qi-Meng Zhang; Jun-Ling Li; Jin-Bin Sun; Tian-Tian Qin; Hong-Bo Liu
Journal:  World J Clin Cases       Date:  2019-08-06       Impact factor: 1.337

Review 5.  Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: A systematic review and meta-analysis.

Authors:  Huanming Xiao; Meijie Shi; Yubao Xie; Xiaoling Chi
Journal:  PLoS One       Date:  2017-11-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.